Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Tuberculosis

  Free Subscription


Articles published in Eur J Clin Microbiol Infect Dis

Retrieve available abstracts of 35 articles:
HTML format



Single Articles


    April 2020
  1. SFAIROPOULOS D, Tsiara S, Barkas F, Margariti PN, et al
    Is brucellosis a great mimic of tuberculosis? A case report.
    Eur J Clin Microbiol Infect Dis. 2020 Apr 24. pii: 10.1007/s10096-020-03902.
    PubMed     Abstract available


    March 2020
  2. MENICHINI M, Lari N, Lupetti A, Rindi L, et al
    Evaluation of Xpert MTB/RIF Ultra assay for rapid diagnosis of pulmonary and extra-pulmonary tuberculosis in an Italian center.
    Eur J Clin Microbiol Infect Dis. 2020 Mar 31. pii: 10.1007/s10096-020-03867.
    PubMed    


    February 2020
  3. UZORKA JW, Duinkerk DL, Kroft LJM, Bakker JA, et al
    Trends in diagnostic methods and treatment of latent tuberculosis infection in a tertiary care center from 2000 to 2017.
    Eur J Clin Microbiol Infect Dis. 2020 Feb 20. pii: 10.1007/s10096-020-03850.
    PubMed     Abstract available


  4. LI J, Zhao A, Tang J, Wang G, et al
    Tuberculosis vaccine development: from classic to clinical candidates.
    Eur J Clin Microbiol Infect Dis. 2020 Feb 15. pii: 10.1007/s10096-020-03843.
    PubMed     Abstract available


    January 2020
  5. SEMINARI E, Monzillo V, Lombardi A, Barbarini D, et al
    Migrations do not modify Mycobacterium tuberculosis resistance rates: a 20-year retrospective study.
    Eur J Clin Microbiol Infect Dis. 2020 Jan 24. pii: 10.1007/s10096-020-03820.
    PubMed     Abstract available


  6. DU J, Shu W, Liu Y, Wang Y, et al
    Multicenter feasibility study to assess external quality panels for molecular diagnostics for tuberculosis in China.
    Eur J Clin Microbiol Infect Dis. 2020 Jan 3. pii: 10.1007/s10096-019-03730.
    PubMed     Abstract available


  7. SHU W, Du J, Liu Y, Wang Y, et al
    External quality control of phenotypic drug susceptibility testing for Mycobacterium tuberculosis in China.
    Eur J Clin Microbiol Infect Dis. 2020 Jan 2. pii: 10.1007/s10096-019-03770.
    PubMed     Abstract available


    December 2019
  8. WEIGL JAI
    Open flanks in the management of tuberculosis in Germany under the pressure of migration.
    Eur J Clin Microbiol Infect Dis. 2019 Dec 17. pii: 10.1007/s10096-019-03791.
    PubMed     Abstract available


  9. DU J, Zhang L, Ma Y, Chen XY, et al
    Treatment and recurrence on re-treatment tuberculosis patients: a randomized clinical trial and 7-year perspective cohort study in China.
    Eur J Clin Microbiol Infect Dis. 2019 Dec 5. pii: 10.1007/s10096-019-03696.
    PubMed     Abstract available


  10. SENTIS A, Vasconcelos P, Machado RS, Cayla JA, et al
    Failure to complete treatment for latent tuberculosis infection in Portugal, 2013-2017: geographic-, sociodemographic-, and medical-associated factors.
    Eur J Clin Microbiol Infect Dis. 2019 Dec 3. pii: 10.1007/s10096-019-03765.
    PubMed     Abstract available


    November 2019
  11. CHEN G, Wang H, Wang Y
    Clinical application of QuantiFERON-TB Gold in-tube in the diagnosis and treatment of tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2019 Nov 30. pii: 10.1007/s10096-019-03768.
    PubMed     Abstract available


  12. TANOGLU A, Erdem H, Friedland JS, Almajid FM, et al
    Clinicopathological profile of gastrointestinal tuberculosis: a multinational ID-IRI study.
    Eur J Clin Microbiol Infect Dis. 2019 Nov 22. pii: 10.1007/s10096-019-03749.
    PubMed     Abstract available


    October 2019
  13. KONTSEVAYA I, Werngren J, Holicka Y, Klaos K, et al
    Non-commercial phenotypic assays for the detection of Mycobacterium tuberculosis drug resistance: a systematic review.
    Eur J Clin Microbiol Infect Dis. 2019 Oct 30. pii: 10.1007/s10096-019-03723.
    PubMed     Abstract available


  14. SAAD J, Loukil A, Drancourt M
    Bead-captured Mycobacterium tuberculosis for next-generation sequencing diagnosis of uncultured tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2019 Oct 14. pii: 10.1007/s10096-019-03700.
    PubMed    


    August 2019
  15. GARCIA-RODRIGUEZ JF, Valcarce-Pardeiro N, Alvarez-Diaz H, Marino-Callejo A, et al
    Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2019 Aug 3. pii: 10.1007/s10096-019-03651.
    PubMed     Abstract available


    July 2019
  16. DU J, Shu W, Liu Y, Wang Y, et al
    Development and validation of external quality assessment panels for mycobacterial culture testing to diagnose tuberculosis in China.
    Eur J Clin Microbiol Infect Dis. 2019 Jul 24. pii: 10.1007/s10096-019-03634.
    PubMed     Abstract available


    April 2019
  17. WEN S, Jing W, Zhang T, Zong Z, et al
    Comparison of in vitro activity of the nitroimidazoles delamanid and pretomanid against multidrug-resistant and extensively drug-resistant tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2019 Apr 5. pii: 10.1007/s10096-019-03551.
    PubMed     Abstract available


    February 2019
  18. MA Y, Che NY, Liu YH, Shu W, et al
    The joint impact of smoking plus alcohol drinking on treatment of pulmonary tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2019 Feb 15. pii: 10.1007/s10096-019-03489.
    PubMed     Abstract available


    January 2019
  19. HODILLE E, Maisson A, Charlet L, Bauduin C, et al
    Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
    Eur J Clin Microbiol Infect Dis. 2019 Jan 24. pii: 10.1007/s10096-018-03463.
    PubMed     Abstract available


    July 2018
  20. CENCI E, Luciano E, Bucaioni M, Rubeca M, et al
    Evaluation of IVD 3.0 Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Mycobacterium tuberculosis and nontuberculous mycobacteria and its use in routine diagnostics.
    Eur J Clin Microbiol Infect Dis. 2018 Jul 14. pii: 10.1007/s10096-018-3326.
    PubMed    


    May 2018
  21. ORIKIRIZA P, Nansumba M, Nyehangane D, Bastard M, et al
    Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting.
    Eur J Clin Microbiol Infect Dis. 2018 May 8. pii: 10.1007/s10096-018-3272.
    PubMed     Abstract available


    April 2018
  22. MA Y, Pang Y, Shu W, Liu YH, et al
    Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up.
    Eur J Clin Microbiol Infect Dis. 2018 Apr 20. pii: 10.1007/s10096-018-3242.
    PubMed     Abstract available


  23. BRODA A, Nikolayevskyy V, Casali N, Khan H, et al
    Experimental platform utilising melting curve technology for detection of mutations in Mycobacterium tuberculosis isolates.
    Eur J Clin Microbiol Infect Dis. 2018 Apr 20. pii: 10.1007/s10096-018-3246.
    PubMed     Abstract available


  24. SEKI M, Kim CK, Hayakawa S, Mitarai S, et al
    Recent advances in tuberculosis diagnostics in resource-limited settings.
    Eur J Clin Microbiol Infect Dis. 2018 Apr 19. pii: 10.1007/s10096-018-3258.
    PubMed     Abstract available


  25. DE GEYTER D, Cnudde D, Van der Beken M, Autaers D, et al
    Evaluation of the Copan Myco-TB kit for the decontamination of respiratory samples for the detection of Mycobacteria.
    Eur J Clin Microbiol Infect Dis. 2018;37:711-714.
    PubMed     Abstract available


    November 2017
  26. LACHMANDAS E, Thiem K, van den Heuvel C, Hijmans A, et al
    Patients with type 1 diabetes mellitus have impaired IL-1beta production in response to Mycobacterium tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2017 Nov 30. pii: 10.1007/s10096-017-3145.
    PubMed     Abstract available


    August 2017
  27. LIN HC, Perng CL, Lai YW, Lin FG, et al
    Molecular screening of multidrug-resistance tuberculosis by a designated public health laboratory in Taiwan.
    Eur J Clin Microbiol Infect Dis. 2017 Aug 24. doi: 10.1007/s10096-017-3082.
    PubMed     Abstract available


  28. NASIRI MJ, Zamani S, Pormohammad A, Feizabadi MM, et al
    The reliability of rifampicin resistance as a proxy for multidrug-resistant tuberculosis: a systematic review of studies from Iran.
    Eur J Clin Microbiol Infect Dis. 2017 Aug 19. doi: 10.1007/s10096-017-3079.
    PubMed     Abstract available


    July 2017
  29. NAMBIAR R, Chatellier S, Bereksi N, van Belkum A, et al
    Evaluation of Mycotube, a modified version of Lowenstein-Jensen (LJ) medium, for efficient recovery of Mycobacterium tuberculosis (MTB).
    Eur J Clin Microbiol Infect Dis. 2017 Jul 6. doi: 10.1007/s10096-017-3052.
    PubMed     Abstract available


    June 2017
  30. HONG MS, Kim Y, Cho EJ, Lee JS, et al
    Comparison of the characteristics of Mycobacterium tuberculosis isolates from sputum and lung lesions in chronic tuberculosis patients.
    Eur J Clin Microbiol Infect Dis. 2017 Jun 15. doi: 10.1007/s10096-017-3025.
    PubMed     Abstract available


  31. MNYAMBWA NP, Kim DJ, Ngadaya ES, Kazwala R, et al
    Clinical implication of novel drug resistance-conferring mutations in resistant tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2017 Jun 7. doi: 10.1007/s10096-017-3027.
    PubMed     Abstract available


    April 2017
  32. WEN HL, Li CL, Li G, Lu YH, et al
    Involvement of methylated HBHA expressed from Mycobacterium smegmatis in an IFN-gamma release assay to aid discrimination between latent infection and active tuberculosis in BCG-vaccinated populations.
    Eur J Clin Microbiol Infect Dis. 2017 Apr 20. doi: 10.1007/s10096-017-2948.
    PubMed     Abstract available


    December 2016
  33. TAN Y, Su B, Zheng H, Wang Y, et al
    Prothionamide susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTECMGIT 960 system.
    Eur J Clin Microbiol Infect Dis. 2016 Dec 20. doi: 10.1007/s10096-016-2859.
    PubMed     Abstract available


    September 2016
  34. KULLIN B, Wojno J, Abratt V, Reid SJ, et al
    Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa.
    Eur J Clin Microbiol Infect Dis. 2016.
    PubMed     Abstract available


    April 2016
  35. SINGH VK, Srivastava R, Srivastava BS
    Manipulation of BCG vaccine: a double-edged sword.
    Eur J Clin Microbiol Infect Dis. 2016;35:535-43.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: